Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2007

View Archived Issues

Snapshots on new candidates to reduce Abeta pathology in AD

Studies in vivo and in healthy volunteers support investigation of AT-2101

Snapshots: studies from the American College of Cardiology annual meeting

PRT-060128 well tolerated, well absorbed in phase I study

Recent patents describe new treatment options for diabetes

Novel antimitotics targeting the kinesin spindle protein presented at the ACS

Novel therapeutic agents for cardiovascular disorders reported in recent patent literature

Nesiritide study provides new renal and mortality safety data

Interim data suggest Nebido trial will meet endpoints

GSK's novel clinical candidate for the treatment of hepatitis C profiled at the ACS meeting

Tekturna and Diovan in combination produce improved blood pressure reduction

Recent Banyu and Lilly patents disclose novel antiobesity agents

Pramiconazole demonstrates efficacy in tinea versicolor

VEGF Trap-Eye improves retinal thickness and visual acuity in wet AMD

Weekly PC-DAC:Exendin-4 lowers blood glucose in type 2 diabetes

New data on gonadotropin-releasing hormone receptor blockers presented

Eltrombopag increases platelet counts in idiopathic thrombocytopenic purpura

OncoGel studied in phase I/II GBM study

Inovio's DNA delivery technology enhances potency of HIV DNA vaccine

FDA approves product enhancements for BeneFIX coagulation factor IX

Preclinical data for deCODE's DG-051 reported at the ACS meeting

Terameprocol studied in phase I/II trial for brain tumors

SSA-426: a novel antidepressant with dual activity on the 5-HT transporter and the 5-HT1A receptor

Resverlogix advances IND preparations for RVX-208

Botox to be studied for paroxysmal trigeminal neuralgia pain

rNAPc2 receives fast track designations in metastatic colorectal cancer

Preliminary phase III plan outlined for faropenem

Polyphenon E Ointment filed in European countries

Avastin approved in E.U. for first-line metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...